» Articles » PMID: 31670901

Effects and Interferences of Emicizumab, a Humanized Bispecific Antibody Mimicking Activated Factor VIII Cofactor Function, on Lupus Anticoagulant Assays

Overview
Specialty Hematology
Date 2019 Nov 1
PMID 31670901
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Emicizumab: the hemophilia A game-changer.

Alcedo Andrade P, Mannucci P, Kessler C Haematologica. 2023; 109(5):1334-1347.

PMID: 37916312 PMC: 11063855. DOI: 10.3324/haematol.2022.282099.

References
1.
Tripodi A, Chantarangkul V, Cini M, Devreese K, Dlott J, Giacomello R . Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study. J Thromb Haemost. 2017; 15(6):1180-1190. DOI: 10.1111/jth.13678. View

2.
Hoxha A, Banzato A, Ruffatti A, Pengo V . Detection of lupus anticoagulant in the era of direct oral anticoagulants. Autoimmun Rev. 2016; 16(2):173-178. DOI: 10.1016/j.autrev.2016.12.010. View

3.
Triplett D, Barna L, Unger G . A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Thromb Haemost. 1993; 70(5):787-93. View

4.
Rampersad A, Boylan B, Miller C, Shapiro A . Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients. Haemophilia. 2018; 24(5):807-814. PMC: 6345165. DOI: 10.1111/hae.13565. View

5.
Kitazawa T, Esaki K, Tachibana T, Ishii S, Soeda T, Muto A . Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens. Thromb Haemost. 2017; 117(7):1348-1357. PMC: 6292136. DOI: 10.1160/TH17-01-0030. View